Purpose: Despite the life-saving benefits of oral anticancer medications (OAMs) to women with breast cancer (BC), adherence remains suboptimal and, in many cases, not well documented. The study examined barriers and facilitators of adherence to OAMs among women receiving BC treatment in Nigeria.
Patients And Methods: The study was framed within the World Health Organization (WHO) Multidimensional Model of Adherence.